HCV - MIGENIX Third Quarter Fiscal 2006 Financial Results Conference Call & Web Cast Notification

MIGENIX Third Quarter Fiscal 2006 Financial Results Conference Call & Web Cast Notification
[Press Release] PR Newswire via Yahoo! Finance - Mar 02 12:58 PM
MIGENIX Inc. , a clinical-stage developer of drugs for infectious and degenerative diseases, will host a conference call and web cast on Wednesday, March 8th, 2006 at 11:00 a.m. ET to discuss financial results for the third quarter of fiscal year 2006 ended January 31, 2006 and provide an update on company activities.Save to My Web

MIGENIX to Participate in "Breakthroughs in Hepatitis" Focus Session at the BIO CEO & Investor Conference in New York
[Press Release] PR Newswire via Yahoo! Finance - Feb 13 10:26 AM
MIGENIX Inc. , a clinical-stage developer of drugs for infectious and degenerative diseases, has been selected to participate in the "Breakthroughs in Hepatitis" focus session at the 8th Annual BIO CEO & Investor Conference in New York City, February 14th and 15th.Save to My Web

Peregrine: Tarvacin Safe in First Trial
AP via Yahoo! Finance - Feb 27 9:44 AM
Peregrine Pharmaceuticals Inc., which develops drugs to treat viral diseases and cancer, on Monday said its Tarvacin drug candidate appeared "safe and well-tolerated" in an early stage clinical study of patients with hepatitis C.Save to My Web

Peregrine advances hepatitis C drug
Pharmaceutical Business Review - Feb 16 6:27 PM
Peregrine Pharmaceuticals, a biopharmaceutical company focusing on viral diseases and cancer, has completed planned patient enrollment and dosing in its initial phase I clinical trial for Tarvacin anti-viral in the treatment of chronic hepatitis C virus infection.Save to My Web

HCV - Sirna Therapeutics Reports Fourth Quarter and Year End 2005 Financial Results

Sirna Therapeutics Reports Fourth Quarter and Year End 2005 Financial Results
RedNova - Mar 01 4:29 PM
SAN FRANCISCO, March 1 /PRNewswire-FirstCall/ -- Sirna Therapeutics, Inc. today reported financial results for the fourth quarter and year ended December 31, 2005.Save to My Web

ViroPharma Announces Presentations at Two Upcoming Conferences
[Press Release] PR Newswire via Yahoo! Finance - Mar 02 9:07 AM
ViroPharma Incorporated today announced that it will present at the Cowen & Company 26th Annual Health Care Conference at 4:00 P.M. Eastern Time on Tuesday, March 7th, 2006.Save to My Web

MEETINGS See Health, Support & Exercise
News Gleaner - Mar 02 8:49 AM
March 2-Rhawnhurst Town Watch, 1910 Ripley Street, 7:30 p.m. 215-333-5412. AARP Crescentville -2nd Sat from Sept. to June (except Dec.) Philadelphia Protestant Home, 6500 Tabor Rd., noon. 215-745-5383.Save to My Web

Ashes bid will be United's goal too
The Journal - Mar 01 12:35 AM
Newcastle United have put their weight behind Durham's bid to bring Ashes cricket to the North-East in 2009 as the Sign the Bat campaign passes the 4,000 mark.Save to My Web

R. Scott Greer Named Chairman of the Board of Sirna Therapeutics and Lutz Lingnau Appointed as New Board Member
[Press Release] PR Newswire via Yahoo! Finance - Mar 01 5:38 AM
Sirna Therapeutics, , a leading RNAi therapeutics company, announced today the appointment of R. Scott Greer to Chairman of the Board and Lutz Lingnau as a new member of the Board of Directors.Save to My Web

HCV - Hepatitis C Virus (HCV): Hep C Support

Hepatitis C Virus (HCV): Hep C Support
Learn More About Hepatitis C Virus (HCV) and Hep C Support Hear from patients about their experiences with hepatitis C. Learn more about hepatitis C

Hepatitis C: Recent Treatment Strategies
It is only very recently that Chinese doctors began checking patients for hepatitis C, a virus that was isolated only a decade ago. It is now found to be a common viral infection in China, though not

Hepatitis C
Hepatitis C The Liver The liver is the largest organ in the body. It is found high in the right upper abdomen, behind the ribs. It is a very complex organ and has many functions

Hepatitis C
Hepatitis C is caused by the hepatitis C virus (HCV), a blood borne infectious agent. The incidence of new HCV infections rose steadily through the 1960s and 1970s and peaked at ~200,000/yr in the

Hepatitis Neighborhood
site providing information and support for those coping with infection by hepatitis C and other forms of viral and non-viral hepatitis. The website offers information about the disease of hepatitis C

Hepatitis C: Index | CDC Viral Hepatitis
Hepatitis C is a disease of the liver caused by the hepatitis C virus (HCV). You may be at risk for hepatitis C and should contact your medical care

HCV - Companies Race to Expand HCV Market Using Bold Approaches

Companies Race to Expand HCV Market Using Bold Approaches
Companies Race to Expand HCV Market Using Bold Approaches by Lucy Sannes, Ph.D., President, Sannes and Associates Dec. 1, 2005-- Hepatitis C virus (HCV) is

HCV Main Page
Efficacy of Pegylated Interferon + Ribavirin in HIV/HCV Co-infection outside of Well-circumscribed Clinical Trials: The Andalusian Multicenter Study

Hepatitis C Selected Articles
The HEP-NET acute-HCV-II study - (02/08/06) Acute hepatitis C: In search of the optimal approach to cure - (02/08/06) Thalidomide in the Treatment of Chronic Hepatitis C Unresponsive to Alfa

HCV ANONYMOUS - Index
Partners ~ Spouses ~ Caregivers Support Forum Share with others that understand. A support forum for those who are not infected - But affected by HCV.

HCV Bulletin Board - Home
Or post new info on what the goverment is doing to help the HCV infected community Moderators: sandi , scarlet 1 1 on Oct 15, 2004, 11:28am by sandi in Ottawa considers openi

HCV - Hepatitis C

Hepatitis C
Title: Hepatitis CCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

Infectious Mononucleosis
Title: Infectious MononucleosisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/14/2005

Hepatitis C Patients Taxing Medical System
Title: Hepatitis C Patients Taxing Medical SystemCategory: Health NewsCreated: 12/31/2005 1:59:00 AMLast Editorial Review: 12/31/2005 1:58:37 AM

GlobeImmune Recruiting for Clinical Trial
While GlobeImmune's therapeutic vaccine for Hepatitis C is only in Phase Ib of clinical trials, their focus on immunity to the Hepatitis C virus is fascinating. GI-5005 is based on tarmogens being potent activators of antigen-specific immune responses against disease....

HCV - OIVD: Home-Use Tests - Hepatitis C

OIVD: Home-Use Tests - Hepatitis C
Hepatitis C infection is caused by the hepatitis C virus (HCV). ... Hepatitis C infection is the number 1 cause for liver transplantation in the US. ...

Hepatitis C: New Treatment Helps Some, but Cure Remains Elusive
Presently, there is no vaccine or other means of preventing hepatitis C infection. HCV exists in many different forms, called genotypes, ...

Hepatitis C Virus Infection: BC HealthFile #40a
Symptoms of acute hepatitis C infection may include fever, tiredness, jaundice (yellow ... People at higher risk of having hepatitis C infection include: ...

Hepatitis C: Tattoo | CDC Viral Hepatitis
CDC's Position on Tattooing and HCV Infection. Although some studies have found an association between tattooing and HCV infection in very selected ...

MedlinePlus Medical Encyclopedia: Hepatitis C
Hepatitis C infection is caused by hepatitis C virus (HCV). ... The prevalence of hepatitis C infection is approximately 4 million people in the United ...

Hepatitis C Virus Infection in Cocaine Users: A Silent Epidemic
The presence of Hepatitis C infection in cocaine users who thought they were healthy suggests a silent epidemic in an unsuspecting population.

HCV - Serono's 2005 Adjusted(i) EPS Increased by 34.6%

Serono's 2005 Adjusted(i) EPS Increased by 34.6%
PR Newswire (press release), NY - Feb 5, 2006... two phase III programs - r-hGH in HIV-associated adipose redistribution syndrome (HARS) - IFN-beta 1a with or without ribavirin in chronic hepatitis C in Asian ...

Peregrine Antiviral Demonstrates Safety in Hepatitis Patients
International News Service, Australia - Feb 28, 2006... data demonstrating that its first-in-class antiviral compound Tarvacin appeared safe and well-tolerated in a phase I study in patients with chronic hepatitis C ...

Human Genome Sciences Reports Financial Results for Full Year and ...
MSN Money - Feb 9, 2006... November 2005, HGS reported the interim results of a Phase 2 trial of Albuferon in combination with ribavirin in patients with chronic hepatitis C who failed ...

XTL Biopharmaceuticals to Present at the JPMorgan Small Cap ...
PR Newswire (press release), NY - Feb 13, 2006... of two monoclonal antibodies against the hepatitis C virus - presently in Phase 1 clinical trials in patients with chronic hepatitis C. XTLbio's hepatitis C ...

HCV - Peregrine Announces Completion of Planned Patient Enrollment and ...

Peregrine Announces Completion of Planned Patient Enrollment and ...
PR Newswire (press release), NY - Feb 15, 2006- HCV Clinical Expert Dr. John McHutchison Also Joins Peregrine SRB - TUSTIN, Calif., Feb. 15 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. ...

Peregrine Announces Completion of Planned Patient Enrollment and ...
Yahoo! News (press release) - Feb 15, 2006TUSTIN, Calif., Feb. 15 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM - News), a biopharmaceutical company ...

Peregrine Announces Completion of Planned Patient Enrollment and ...
PharmaLive.com (press release), PA - Feb 15, 2006TUSTIN, Calif., February 15, 2006 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company with a ...

HCV - Hepatitis C Virus Lives In Your Liver(NC)-Your liver

Hepatitis C Virus Lives In Your Liver

(NC)-Your liver works 24 hours a day, performing over 500 vital functions for your body. Most of the blood that returns to your heart passes through the liver. Your body can't function without it.

The hepatitis C virus lives in your liver. It inflames liver cells, which, over time, affects the way your liver functions. The effect of the hepatitis C virus varies from person to person. There is no way to predict how your body will react to it. There are, however, some things that are known:

You can live with hepatitis C for many years without experiencing any major symptoms, or you might simply feel tired. Symptoms can come and go over time. Their presence or absence does not tell you the degree to which liver damage may or may not be occurring. p>

Chronic, long-term inflammation of the liver can cause liver cell damage and result in fibrosis (liver scarring), or even cirrhosis. This damage can occur in as little as five years, or as long as 30 years.

About 20% of chronic hepatitis patients develop cirrhosis within 10 to 20 years.

Use of recreational drugs or alcohol can speed up inflammation and the development of fibrosis or cirrhosis.

There is an increased risk of liver cancer in people with cirrhosis.

The good news is that current drug treatments can be very effective for people with hepatitis C. Combined with proper nutrition, plenty of rest, and avoidance of recreational drugs and alcohol, these treatments help many who have the virus lead relatively healthy lives.

If you think you may be at risk of getting hepatitis C, see your doctor. The virus can be detected by a simple blood test. For more information on how to keep your liver happy and healthy, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

p>

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services. p>

HCV - Peregrine Announces Completion of Planned Patient Enrollment and Dosing in Initial Tarvacin(TM) Anti-Viral Hepatitis C

Peregrine Announces Completion of Planned Patient Enrollment and Dosing in Initial Tarvacin(TM) Anti-Viral Hepatitis C
[Press Release] PR Newswire via Yahoo! Finance - Feb 15 4:00 AM
Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it has completed planned patient enrollment and dosing in its initial Phase l clinical trial for Tarvacin Anti-Viral in the treatment of chronic hepatitis C virus infection .Save to My Web

HCV - HCV Hepatitis C Anonymous - 12 Steps - Home Page - Hep C Virus - 12 Steps & Meetings

HCV Hepatitis C Anonymous - 12 Steps - Home Page - Hep C Virus - 12 Steps & Meetings
HCV Hepatitis Anonymous supplies current hepatitis news & information on Hepatitis C (HCV), 12 steps, big book, positive attitudes, online HCV meetings and live chat!!

A Hepatitis C Primer
Resource for anyone wanting to learn more about the virus. Includes medical research as well as personal experiences.

CBC News: Money unfairly spent: hep C victims
... Money unfairly spent: hep C victims. Last Updated Wed, 06 Oct 2004 10:44:17 EDT ... FROM MAY 22, 2001: Hep C victims say money being misdirected ...

HEP "C" SUPPORT GROUP
THE ULTIMATE PHYSICIAN IS. SEVEN DAYS A WEEK - NO DEDUCTABLES OR CO - PAYS - GOD IS THE BEST INSURANCE THAT MONEY CAN'T BUY YOU. USE TO SEARCH HEP "C" ARTICLES FROM THIS SITE. &nbsp

Hepatitis Information Network: Hepatitis C
News, epidemiology, natural history, and notes on the management and treatment of the disease.

HCV - Doctor: Checklist to Take To Your Doctor's Appointment

Doctor: Checklist to Take To Your Doctor's Appointment
Title: Doctor: Checklist to Take To Your Doctor's AppointmentCategory: Health FactsCreated: 7/13/2005Last Editorial Review: 7/14/2005

Hepatitis B
Title: Hepatitis BCategory: Diseases and ConditionsCreated: 1/26/2001 11:58:00 AMLast Editorial Review: 9/21/2005

Health Tip: Nail Salon Safety
Title: Health Tip: Nail Salon SafetyCategory: Health NewsCreated: 4/12/2005 1:59:00 AMLast Editorial Review: 4/12/2005 1:58:31 AM

Hepatitis C
Title: Hepatitis CCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

HCV - Conclusions About Milk Thistle

Conclusions About Milk Thistle
A May 2005 review of clinical studies which casts doubt on milk thistle's value has recently been re-released into the press. Alternatively, an extensive amount of research supports the continued usage of this herb at higher dosages. Researchers of the...

Indenix is Nearing Phase III for Valopicitabine
It is always good to see progress with alternatives to current medical therapy for HCV. Even though companies that are working on solutions to be used with interferon are not really offering anything groundbreaking or revolutionary, it does continue the...

MedMira Rapid Test
The start of the New Year was accompanied by the European Patent Office granting a patent for a rapid HCV test. Now that the technology is here, let's hope the test proves accurate, with high levels of selectivity and specificity....

Hepatitis B
Title: Hepatitis BCategory: Diseases and ConditionsCreated: 1/26/2001 11:58:00 AMLast Editorial Review: 9/21/2005

Infectious Mononucleosis
Title: Infectious MononucleosisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/14/2005

HCV - Millenia Hope Acquires AIDS Patent

Millenia Hope Acquires AIDS Patent
[Press Release] PR Newswire via Yahoo! Finance - Feb 28 5:34 AM
Millenia Hope Inc., a biopharma corporation , has acquired a patent on AIDS that specifically describes compounds that inhibit HIV-1 RNase_H.Save to My Web

Clinical Trial Results Show that Peregrine's First-In-Class Anti-Viral Agent Tarvacin(TM) is Safe and Well-Tolerated in
[Press Release] PR Newswire via Yahoo! Finance - Feb 27 4:00 AM
Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it will present top line data demonstrating that its first-in-class anti-viral compound Tarvacin Anti-Viral appeared safe and well-tolerated in a Phase l study in chronic hepatitis C virus infected patients.Save to My Web

Clinical Trial Results Show That Peregrine's First-In-Class Anti-Viral Agent Tarvacin(TM) Is Safe And Well-Tolerated In
Medical News Today - Feb 27 4:06 PM
Peregrine Pharmaceuticals, Inc. (PPHM), a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it will present top line data demonstrating that its first-in-class anti-viral compound Tarvacin(TM) Anti-Viral appeared safe and well-tolerated in a Phase l study in chronic hepatitis C virus (HCV) infected Save to My Web

Experts warn public on dangers of Hep C
Australian Broadcasting Corporation - Feb 18 12:12 AM
ELIZABETH JACKSON: Health experts are warning that Australia doesn't have the resources to deal with a burgeoning epidemic of viral hepatitis, a debilitating disease, which affects the liver.Save to My Web

HCV - Third Wave, Chiron, Bayer dismiss HCV patent suit

Third Wave, Chiron, Bayer dismiss HCV patent suit
Reuters UK - CHICAGO (Reuters) - Third Wave Technologies Inc. on Thursday said it reached an agreement with Chiron Corp. and Bayer Corp. to dismiss its lawsuit against Chiron and Bayer over patents related to hepatitis C virus, or HCV. Terms of the agreement were

Viral hepatitis C management involves some tough decisions
Managed Healthcare Executive - From a care delivery standpoint, identifying and treating patients with the hepatitis C virus (HCV) is a complicated and difficult process. It's the most prevalent liver disease in the world, with as many as 300 million people afflicted with the

Peregrine Pharmaceutical Will Deliver Hepatitus C Phase I Safety Data
Medical News Today - Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it has completed planned patient enrollment and dosing

Drug cocktail offers hope for HCV sufferers
Daily Yomiuri On-Line - I am infected with the hepatitis C virus. But the virus has been eliminated from my blood thanks to a new treatment that uses a cocktail of peginterferon and ribavirin. This new combination may be a cure for many people with HCV. I have been taking

HCV - A Summary of Chronic Hepatitis C InfectionHepatitis C

A Summary of Chronic Hepatitis C Infection

Hepatitis C is a stealthy virus that mutates while hiding in liver cells and other organ cells like the spleen and gall bladder. The fact that the viral cells "hide" makes it very difficult for the body's immune system to eradicate it. Hepatitis C is a slowly progressing disease sometimes taking many years until symptoms are noticeable. It is at this point that the virus has reached advanced chronic stage and becomes difficult to eradicate. Hepatitis C results in 8,000 to 10,000 deaths annually. Hepatitis C is also the leading cause of liver transplants in the U.S.

Hepatitis C infection is caused by blood contact with someone who has the virus infection himself. The transmission of the virus can occur by illicit drug use with needles, sharing toothbrushes or razors with an infected person, by sexual means, by unsanitary tattooing or by exposure to blood at your workplace (like a hospital or blood bank). Some HCV infection may have been caused by receiving blood from a transfusion prior to 1992.

Hepatitis C is diagnosed via a blood test. Usually, the first thing that is noticed is that the liver enzyme levels for ALT and AST are elevated well above normal levels. Further investigation via HCV-RNA testing identifies whether the Hepatitis C virus is in your blood or not. Other tests for HCV include qualitative viral load tests, which measure the RNA particles in your blood. If you are being treated for HCV, your doctor is probably using either a HCV-RNA or viral load test to determine the effectiveness of the treatment.

The symptoms of Hepatitis C infection often do not occur in a person until 20 years after he/she had been infected. Since the HCV infects the liver and the liver is the organ in the body that makes all the energy for our daily activities possible, liver function deterioration often results in fatigue. Fatigue is the primary complaint or symptom of HCV infection. Other more severe symptoms are jaundice (yellowing of the skin/eyes), bile retention (which can cause jaundice), portal vein hypertension, skin rashes and itching, and autoimmune problems resulting from your body's immune system attacking normal cells.

Long term HCV infection may result in fibrosis or even cirrhosis of the liver. Fibrosis results from unchecked liver inflammation. As the HCV infection progresses, the damage to the liver results in scarring or hardening of the liver cells (fibrosis). Long term fibrosis may lead to cirrhosis which is when the scarring from fibrosis overtakes the normal liver cell structure causing deformity and loss of function in the liver. About 15%-20% of HCV patients end up with cirrhosis. A liver biopsy is currently the most accurate means of determining the amount of inflammation and fibrosis the liver has sustained.

Hepatitis C progression in the body can take several years or even decades to come to chronic stage or to a stage where severe liver damage is evident. This period of time allows a person to determine how to properly treat the disease and to decide on a course of disease management. Currently, the main treatment for HCV infection to eradicate the virus is combo alpha-interferon and Ribavirin. Sometimes a doctor may prescribe interferon alone. Interferon comes in standard form or in pegylated form. Standard form interferon is administered 3 times per week, while the pegylated form is administered only once per week. Your body makes its own interferon, which is a protein that fights viral infection and viral replication.

Hepatitis C may often be managed by taking herbal and vitamin supplements that help your body fight infection and limit inflammation. These supplements help your liver with the inflammation and give it the nutrients it needs to regenerate healthy new cells. Your doctor can recommend alternative or adjunct solutions you may want to try.

Proper treatment of the disease, a healthy and active lifestyle, a good diet, abstinence from alcohol and stress management are important factors in controlling Hepatitis C progression.

About the Author

Greg Lietz is a freelance writer and internet businessman. His main website is http://www.theonlinebizplace.com where he provides content about internet based business opportunities and different niche interests. This article may be freely printed when the bio information is included.

HCV - Hep-C

Hep-C
HEPATITIS C BEHIND BARS. by Corey Weinstein, MD ... 000 of a $2,000,000 grant for Hep C care because it couldn't figure out how to ... One important thing is that Hep C virus is much easier to ...

KeepMedia | Esquire: What Is a Pandemic?
... heart disease still kill far more Americans than hep C does each year--but there's no question that ... The bottom line is, hep C now kills about ten thousand people ...

Hepatitis C Web Portal: Welcome
Hepatitis Hepatitis C Hep C HCV Interferon Liver Liver disease Co-infection Contracting Hepatitis C Facts about Hepatitis C Treating Hepatitis C What is Hepatitis C cure drugs diagnosis facts guide groups help health information medications ...

Hepatitis C news, articles and studies, hep c information
... Interferon Slows Hep C Progression: Research Confirms Low-Dose Therapy Works for Long-Term ... HCV Maintenance Therapy From Hep C Advocate. Liz Highleyman, Contributing Editor 2002 ...

Hep C straightup - you're Home
Got Hep C? Get the straightup. Living with hepatitis C isn't easy. Geared toward the biker community and I'm talking Harleys here Hep C straightup exists to provide the straight up about this disease. It's important to be well armed ...

HCV - Hep C key lies in new needles, not education

Hep C key lies in new needles, not education
Australian, Australia - Feb 19, 2006... About 75 per cent of people infected are likely to progress to chronic hepatitis C, with the virus in the bloodstream for more than six months. ...

XTL Biopharmaceuticals to Present at the JPMorgan Small Cap ...
PR Newswire (press release), NY - Feb 13, 2006... of two monoclonal antibodies against the hepatitis C virus - presently in Phase 1 clinical trials in patients with chronic hepatitis C. XTLbio's hepatitis C ...

Viral Hepatitis and HIV Coinfection
Medscape (subscription) - Feb 3, 2006... After adjusting for chronic hepatitis C, the frequency of isolated anti-HBc did not differ when comparing HIV-infected and HIV-uninfected women. ...

MIGENIX to Participate in "Breakthroughs in Hepatitis" Focus ...
Canada NewsWire (press release), Canada - Feb 13, 2006... and will present MIGENIX's celgosivir (MX-3253), a first-in-class alpha glucosidase 1 inhibitor for the treatment of chronic Hepatitis C infections. ...